Table 2 Incident rates and hazard ratios of incident apparent treatment resistant hypertension for JHS participants with hypertension enrolled in 2000–2004, by quartiles of urinary sodium.
Incident aTRH | Quartiles of urinary sodium | P Value for Trenda | |||
|---|---|---|---|---|---|
Quartile 1 (253 to 2530 mg) N = 113 | Quartile 2 (2553 to 3657 mg) N = 113 | Quartile 3 (3680 to 4692 mg) N = 113 | Quartile 4 (4715 to 9775 mg) N = 113 | ||
Cases, n (%) | 29 (25.7%) | 28 (24.8%) | 33 (29.2%) | 33 (29.2%) | 0.166 |
Event Summary, | |||||
At Visit 2 (cases/no. at risk) | 17/96 | 16/100 | 25/97 | 19/102 | |
At Visit 3 (cases/no. at risk) | 12/64 | 12/75 | 8/64 | 14/73 | |
HR (95% CI) | |||||
Model 1ǂ | 1.00 (reference) | 0.88 (0.52, 1.51) | 1.14 (0.67, 1.94) | 1.04 (0.61, 1.80) | |
Model 2§ | 1.00 (reference) | 0.66 (0.32, 1.35) | 0.95 (0.50, 1.82) | 0.87 (0.44, 1.70) | |
Model 3ǁ | 1.00 (reference) | 0.71 (0.34, 1.46) | 1.02 (0.50,2.06) | 0.95 (0.46, 2.00) | |